We anticipate that targeting CFTR dependent lipid-rafts in CS-COPD can control chronic infection and inflammation by improving CFTR dependent phagocytosis and pro-inflammatory responses [6,12,68,69]. Here, CFTR is linked to chronic obstructive pulmonary disease.